提交
This commit is contained in:
@@ -40,75 +40,62 @@
|
||||
<span class="anchor-text">Cancer Advances</span>
|
||||
</a> -->
|
||||
<!-- 暂时去掉 -->
|
||||
<span class="js-title-evolution-prefix ">
|
||||
<div class="js-title-evolution-prefix ">
|
||||
|
||||
<!-- <span class="have-italic">Aging Communications</span> was merged into <span
|
||||
class="have-italic">Life Research</span> (ISSN 2624-0548). This strategic
|
||||
decision aims to enhance the scope of our platform for research in <span
|
||||
class="have-italic">Life Research</span>.
|
||||
<span class="have-italic">Life Research</span> is a peer-reviewed, open access (OA)
|
||||
academic journal managed by TMR
|
||||
Publishing Group. The aim of <span class="have-italic">Life Research</span> is to
|
||||
supply
|
||||
a platform to explore the
|
||||
scientific connotation and new finding of Animal, Plant, Microbial, etc. related to
|
||||
life research based on a scholarly view. <span class="have-italic">Life
|
||||
Research</span> covers molecular biology,
|
||||
neurobiology, zoology, botany, aging, etc. For the latest published articles, please
|
||||
visit <a class="anchor anchor-default" href="/lr/" target="_blank"
|
||||
usagezone="jrnl_info">
|
||||
<span class="anchor-text ">Life Research</span>
|
||||
</a>. -->
|
||||
|
||||
<div >Notice of Suspension of Publication</div><br/>
|
||||
<div >
|
||||
Dear Authors, Reviewers, and Readers,<br/>
|
||||
|
||||
We would like to extend our sincere gratitude for your continued support and
|
||||
attention to <span class="have-italic">Pharmacology Discovery</span>. After
|
||||
<div>Notice of Suspension of Publication</div><br />
|
||||
<div>Dear Authors, Reviewers, and Readers,</div><br />
|
||||
<div>We would like to extend our sincere gratitude for your continued support and
|
||||
attention to <span class="have-italic">Clinical Research Communications</span>.
|
||||
After
|
||||
thorough consideration and discussion, we regret to inform you that <span
|
||||
class="have-italic">Pharmacology Discovery</span> will stop publication on
|
||||
May 1, 2025.<br/>
|
||||
|
||||
This decision was made after considering operational costs and the restructuring
|
||||
class="have-italic">Clinical Research Communications</span> will stop
|
||||
publication on
|
||||
May 1, 2025.</div><br />
|
||||
<div>This decision was made after considering operational costs and the
|
||||
restructuring
|
||||
of the publication group. We understand that this news may cause inconvenience,
|
||||
and we sincerely apologize to all authors, reviewers, editorial teams, and
|
||||
readers who have supported the journal over the years.<br/>
|
||||
</div>
|
||||
readers who have supported the journal over the years.</div><br />
|
||||
|
||||
<div ><b>Regarding Submitted and Upcoming Manuscripts:</b></div><br/>
|
||||
<div >
|
||||
|
||||
<div><b>Regarding Submitted and Upcoming Manuscripts:</b></div><br />
|
||||
<div>
|
||||
<ul>
|
||||
<li>1.For manuscripts that have already been submitted but not yet published,
|
||||
<li>1.For manuscripts that have already been submitted but not yet
|
||||
published,
|
||||
we will contact the respective authors before May 1 to facilitate the
|
||||
transfer of the manuscripts to other relevant journals. The manuscript
|
||||
handling process will not be affected by the transfer.</li><br/>
|
||||
handling process will not be affected by the transfer.</li><br />
|
||||
<li>2.For manuscripts that have not yet been submitted, we kindly suggest
|
||||
authors select other suitable journals for submission.</li><br/>
|
||||
authors select other suitable journals for submission.</li><br />
|
||||
<li>3.Accepted manuscripts will be published as originally planned, with all
|
||||
articles that are pre-published to be made available before May 1.</li>
|
||||
</ul>
|
||||
</div>
|
||||
|
||||
<div ><b>Data Archiving and Retrieval:</b></div><br/>
|
||||
<div >
|
||||
<br />
|
||||
<div><b>Data Archiving and Retrieval:</b></div><br />
|
||||
<div>
|
||||
All published articles will remain in our database and will continue to be
|
||||
accessible through the provided Digital Object Identifiers (DOIs) and official
|
||||
website. These articles will remain indexed and available for citation.<br/>
|
||||
website. These articles will remain indexed and available for citation.
|
||||
</div>
|
||||
<br />
|
||||
<div>
|
||||
<p> Once again, we express our deepest gratitude for your ongoing support of
|
||||
<span class="have-italic">Clinical Research Communications</span>, and we
|
||||
hope to
|
||||
collaborate again in the future on other platforms.
|
||||
</p>
|
||||
<br />
|
||||
<p>Sincerely,</p><br />
|
||||
<p> <span class="have-italic">Clinical Research Communications</span></p><br />
|
||||
<p>April 29, 2025</p><br />
|
||||
<p>TMR Publishing Group</p>
|
||||
|
||||
</div>
|
||||
|
||||
<div >
|
||||
Once again, we express our deepest gratitude for your ongoing support of <span
|
||||
class="have-italic">Pharmacology Discovery</span>, and we hope to
|
||||
collaborate again in the future on other platforms.<br/>
|
||||
|
||||
Sincerely,<br/>
|
||||
<span class="have-italic">Pharmacology Discovery</span><br/>
|
||||
April 29, 2025<br/>
|
||||
TMR Publishing Group
|
||||
</div>
|
||||
|
||||
</span>
|
||||
</div>
|
||||
</div>
|
||||
</div>
|
||||
</div>
|
||||
|
||||
Reference in New Issue
Block a user